AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dubatran 500mg Injection

Prescription Icon
Prescription Required

Marketer

Alembic Pharmaceuticals Ltd

Salt Composition

Tranexamic Acid (500mg)

Overview Dubatran 500mg Injection

Tranxifib 500mg Injection is indicated for hemorrhage management. It aids in preventing or minimizing blood loss associated with procedures such as dental extractions, menorrhagia, abnormal uterine bleeding, epistaxis, and surgeries involving the oral cavity, prostate, or bladder. Tranxifib 500mg Injection functions as an antifibrinolytic agent, inhibiting clot dissolution and thus controlling bleeding. Administration should always be overseen by a qualified medical practitioner. Contraindicated in individuals with hypersensitivity to the injection's components. Frequently reported adverse reactions include local injection site responses, fatigue, musculoskeletal discomfort, and rhinorrhea. Prior cardiac surgery or renal impairment should be disclosed to your physician. This injection is considered safe for use during pregnancy and lactation, and in patients with hepatic disease.

Uses of Dubatran 500mg Injection

Managing Hemorrhage

Major Benefits of Dubatran 500mg Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

Common Side effects of Dubatran 500mg Injection:

  • Joint pain
  • Headache
  • Back pain
  • Vomiting
  • Nausea
  • Abdominal pain
  • Diarrhea
  • Muscle cramp
  • Anemia (low number of red blood cells)
  • Lightheadedness

How to use Dubatran 500mg Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is not advised.

How Dubatran 500mg Injection works:

Tranexamic acid 500mg injection counteracts excessive bleeding by inhibiting clot dissolution. Its anti-fibrinolytic action is beneficial for managing menstrual hemorrhage and post-surgical bleeding.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Dubatran 500mg Injection and alcohol can lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on the administration of 500mg Dubatran injections to pregnant individuals is absent. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Dubatran 500mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer via breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The impact of Dubatran 500mg Injection on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Dubatran 500mg Injection cautiously. A modified dosage of Dubatran 500mg Injection might be necessary. Physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The 500mg Dubatran injection is likely safe for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.

What if you forget to take Dubatran 500mg Injection :

Omit a scheduled Dubatran 500mg injection? Seek your physician's advice.

Facts to Know About Dubatran 500mg Injection

LabelValue
Type of Compound Amino acid and peptide analogs.
Addictive None.
Medication Classification HEMATOLOGICAL

FAQs on Dubatran 500mg Injection

Intramuscular administration of Dubatran 500mg Injection is contraindicated. To minimize adverse reactions, intravenous administration via slow injection is mandatory.
All medications carry potential side effects; however, adhering to prescribed usage significantly reduces this risk. The advantages of medication typically outweigh the likelihood of adverse reactions. In rare instances, Dubatran 500mg Injection may produce severe, potentially life-threatening side effects such as anaphylaxis (characterized by hives, respiratory distress, and facial, oral, or periorbital swelling), thromboembolism, or ophthalmological complications. Prior to commencing this treatment, a physician's consultation is essential, and all instructions must be followed meticulously.
Dubatran 500mg Injection facilitates blood coagulation, reducing hemorrhaging. Nevertheless, thrombosis in the deep leg veins (DVT) may occur infrequently. Studies suggest contributing factors beyond the injection itself may increase this risk, which appears elevated in women using Dubatran 500mg Injection. Physician consultation prior to commencing treatment and adherence to prescribed guidelines are essential.
Long-term Dubatran 500mg Injection therapy may cause alterations in color perception. Therefore, routine eye examinations are recommended throughout treatment. Report any visual changes to your physician immediately; they may discontinue the medication and prescribe an alternative if necessary.
Dubatran 500mg Injection facilitates coagulation and, in rare instances, may lead to a blood clot migrating to the lungs (pulmonary embolism), potentially resulting in death. While infrequent in patients using Dubatran 500mg Injection, pulmonary embolism is associated with overdose, prolonged immobility, or predisposed individuals. Research indicates that other contributing factors may also elevate the risk of thrombosis.
A single 500mg dose of Dubatran Injection may be administered with or without food, accompanied by water. The medication must be swallowed intact; crushing or chewing is prohibited.
Treatment length and dosage for this medication vary depending on the diagnosed condition. In cases of severe menstrual bleeding, a typical course lasts five days. However, for other conditions, the physician may prescribe a shorter or longer treatment period.
Dubatran 500mg Injection has no documented impact on fertility. Prescribed for the management of menorrhagia, available data indicates no disruption of ovulation. Consequently, it's not a contraceptive and won't hinder pregnancy.
Epistaxis can be treated with a 500mg Dubatran injection, which promotes blood clotting and hemostasis. For recurrent nosebleeds, the medication may be administered for up to seven days.
Dubatran 500mg Injection
32
MRP 39
18% off